The following information is from the House Committee on Energy and Commerce. In a new letter to Attorney General Merrick Garland and Department of Health and Human Services (HHS) Secretary Xavier Becerra, House Energy and Commerce Committee Chair Cathy McMorris […]
The following is from The Vaccine Reaction. Pfizer, Inc., the largest pharmaceutical corporation in the world marketing drugs and vaccines, has agreed to pay between $200 to $250 million to settle more than 10,000 lawsuits filed in the United States
Pfizer settles Zantac cancer lawsuits for $250 million Read More »
Children’s Health Defense (CHD) has petitioned the Supreme Court to hear its case against the FDA for granting Emergency Use Authorization of Covid-19 vaccines for children and infants. CHD’s lawsuit, filed with five other plaintiffs who are parents of children ages two months to 13
The following is an excerpt from The Defender. Clinical researchers no longer have to obtain informed consent from human subjects when their research poses “no more than minimal risk,” the U.S. Food and Drug Administration (FDA) ruled last week. The new rule
(FDA) Informed consent not required for ‘minimal risk’ studies Read More »
The following is an excerpt from The Vaccine Reaction. In recent years, government health agencies, cancer societies, as well as the American Dental Association (ADA), have attempted to recruit dentists to advocate for patients to get the human papillomavirus (HPV)
US taxpayer funds being used to train dentists to promote HPV vaccine Read More »
House Committee on Oversight and Accountability Chairman Rep. James Comer (R-Kentucky) and Subcommittee on Health Care and Financial Services Chairwoman Rep. Lisa McClain (R-Michigan) are asking about the FDA response to a growing number of critical drug shortages. Some of
(READ) House Republicans probe FDA response to national drug shortage Read More »
The following is an excerpt from The Vaccine Reaction. On Jan. 13 2023, the U.S. Food and Drug Administration (FDA) and the U.S. Centers for U.S. Disease Control and Prevention (CDC)) issued a public statement regarding the identification of a
Public Citizen’s Health Research Group wants the FDA to deny speeded up approval of a new gene therapy treatment. The advocacy group states that the treatment, SRP-9001 (Sarepta Therapeutics) for ambulatory Duchenne muscular dystrophy (DMD), intended for children aged four
(READ) Watchdogs want FDA to reject fast-tracking of new gene therapy treatment Read More »
